Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsant hypersensitivity syndrome.

Sukhjot Kaur1, Rashmi Sarkar, Gurvinder P Thami

  • 1Department of Dermatology and Venereology, Government Medical College and Hospital, Chandigarh, India.

Pediatric Dermatology
|May 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Expert Consensus on the Management of Hyperpigmentation Disorders in India: A Modified Delphi Study by the Pigmentary Disorders Society.

International journal of dermatology·2026
Same author

Rural Dermatology in the Subtropics: A Cross-Sectional Study of Patterns of Dermatoses, Follow-Up Visits, and Treatment Compliance at a Rural Health Center in North India.

The American journal of tropical medicine and hygiene·2026
Same author

When Does Pigment Matter? Toward a Context-Aware Standard for Representation in Dermatology.

International journal of dermatology·2026
Same author

Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience.

Indian journal of dermatology·2026
Same author

An Unusual Case of Mycetoma Caused by Fusarium solani.

Indian dermatology online journal·2026
Same journal

Adverse Childhood Experiences and Pediatric Dermatology: Implications for Care, Equity, and Research.

Pediatric dermatology·2026
Same journal

State-of-the-Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review.

Pediatric dermatology·2026
Same journal

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa.

Pediatric dermatology·2026
Same journal

Infantile Transient Smooth Muscle Contraction of the Skin in Two Sisters.

Pediatric dermatology·2026
Same journal

Are 2021 CMS Changes Enough to Address the Pediatric Dermatology Crisis?

Pediatric dermatology·2026
Same journal

Annular Eruption in 12-Year-Old Boy.

Pediatric dermatology·2026
See all related articles

Anticonvulsant hypersensitivity syndrome is a severe reaction to aromatic antiepileptic drugs like carbamazepine and phenytoin. Prompt recognition and treatment are crucial for managing this potentially fatal drug reaction.

Area of Science:

  • Pharmacology
  • Toxicology
  • Clinical Medicine

Background:

  • Anticonvulsant hypersensitivity syndrome (AHS) is a severe, idiosyncratic drug reaction.
  • It is associated with aromatic antiepileptic drugs (AEDs) including phenytoin, carbamazepine, phenobarbital, and primidone.
  • AHS typically manifests 2-8 weeks after starting AED therapy.

Observation:

  • Hallmark clinical features include fever, rash, and lymphadenopathy.
  • Hematologic abnormalities like eosinophilia and atypical lymphocytes are common.
  • Internal organ involvement can occur with varying severity.

Findings:

  • This report details a case of AHS caused by carbamazepine.
  • Cross-sensitivity between carbamazepine and phenytoin was observed in this case.

Related Experiment Videos

  • The diverse clinical presentations of AHS necessitate prompt recognition.

    • Implications:

    • Early identification of AHS is critical for timely intervention.
    • Understanding cross-sensitivity patterns aids in managing patients on AEDs.
    • This syndrome highlights the importance of vigilant monitoring for adverse drug reactions.